Botulinum toxin and eyelid ptosis: A narrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v13i10.47022

Keywords:

Botulinum Toxins, Type A, Blepharoptosis, Face.

Abstract

Botulinum toxin type A (BoNT-A) is widely used in aesthetic and therapeutic procedures, being one of the most effective interventions for smoothing expression lines. However, one of the potential adverse effects is eyelid ptosis, which refers to the drooping of the upper eyelid due to the unintended diffusion of the toxin to the levator palpebrae muscle. This effect, although temporary, can cause both aesthetic and functional discomfort for patients. The proposed narrative review aims to comprehensively examine the literature on the association between the use of botulinum toxin and eyelid ptosis, identifying risk factors, the mechanisms of action involved, and strategies to mitigate this complication. By addressing these issues, the goal is to provide a thorough understanding for professionals using BoNT-A in their practices, in order to improve the safety and efficacy of the procedure. The review also aims to identify gaps in current research and suggest directions for future investigations on how to prevent eyelid ptosis, ensuring greater patient satisfaction.

Downloads

Download data is not yet available.

References

Almeida, T. C. M., & Couto, N. C. (2023). Intercurrences caused by botulinum toxin in aesthetics. Research, Society and Development, 12(11), e38121143683. https://doi.org/10.33448/rsd-v12i11.43683

Bacharach, J., Lee, W. W., Harrison, A. R., & Freddo, T. F. (2021). A review of acquired blepharoptosis: prevalence, diagnosis, and current treatment options. Eye (London, England), 35(9), 2468–2481. https://doi.org/10.1038/s41433-021-01547-5

Bernardini, F. P., de Conciliis, C., & Devoto, M. H. (2006). Mini-invasive ptosis surgery. Orbit (Amsterdam, Netherlands), 25(2), 111–115. https://doi.org/10.1080/01676830600671425

Fea, A., Damato, D., Actis, A. G., De Sanctis, U., Actis, G., & Grignolo, F. M. (2013). Blepharoplastic: essential review. Minerva chirurgica, 68(6 Suppl 1), 49–56.

Finsterer J. (2003). Ptosis: causes, presentation, and management. Aesthetic plastic surgery, 27(3), 193–204. https://doi.org/10.1007/s00266-003-0127-5

Francisco Filho, M. L., Suguihara, R. T., & Muknicka, D. P. (2023). Mechanisms of action and indication of Botulinum Toxin. Research, Society and Development, 12(6), e15712642223. https://doi.org/10.33448/rsd-v12i6.42223

Liu, C. Y., Chhadva, P., & Setabutr, P. (2018). Blepharoptosis repair. Current opinion in otolaryngology & head and neck surgery, 26(4), 221–226. https://doi.org/10.1097/MOO.0000000000000463

Martel A. (2022). Conduite à tenir devant un ptosis [Management of ptosis]. Journal francais d'ophtalmologie, 45(2), 233–246. https://doi.org/10.1016/j.jfo.2021.09.005

Martin J. J., Jr (2013). Ptosis repair in aesthetic blepharoplasty. Clinics in plastic surgery, 40(1), 201–212. https://doi.org/10.1016/j.cps.2012.06.007

Nemet A. Y. (2019). Primary Lash Ptosis. The Journal of craniofacial surgery, 30(7), 2249–2250. https://doi.org/10.1097/SCS.0000000000005984

Ng, J., & Hauck, M. J. (2013). Ptosis repair. Facial plastic surgery : FPS, 29(1), 22–25. https://doi.org/10.1055/s-0033-1333831

Omoigui, S., & Irene, S. (2005). Treatment of ptosis as a complication of botulinum toxin injection. Pain medicine (Malden, Mass.), 6(2), 149–151. https://doi.org/10.1111/j.1526-4637.2005.05029.x

Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).

SooHoo, J. R., Davies, B. W., Allard, F. D., & Durairaj, V. D. (2014). Congenital ptosis. Survey of ophthalmology, 59(5), 483–492. https://doi.org/10.1016/j.survophthal.2014.01.005

Steinsapir, K. D., Groth, M. J., & Boxrud, C. A. (2015). Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 41(7), 833–840. https://doi.org/10.1097/DSS.0000000000000386

Tenzel, P. A., Brown, K., Zhou, B., Itani, K. M., & Mancini, R. (2022). Facial Asymmetry in Children With Unilateral Congenital Ptosis. Ophthalmic plastic and reconstructive surgery, 38(5), 483–489. https://doi.org/10.1097/IOP.0000000000002174

Weaver D. T. (2018). Current management of childhood ptosis. Current opinion in ophthalmology, 29(5), 395–400. https://doi.org/10.1097/ICU.0000000000000508

Wojno T. (2021). Commentary on: A Comprehensive Approach to Asian Upper Eyelid Ptosis Correction: The Levator Musculo-Aponeurotic Junction Formula. Aesthetic surgery journal, 41(10), 1130–1131. https://doi.org/10.1093/asj/sjab018

Wolfort, F. G., & Poblete, J. V. (1995). Ptosis after blepharoplasty. Annals of plastic surgery, 34(3), 264–267. https://doi.org/10.1097/00000637-199503000-00007

Zoumalan, C. I., & Lisman, R. D. (2010). Evaluation and management of unilateral ptosis and avoiding contralateral ptosis. Aesthetic surgery journal, 30(3), 320–328. https://doi.org/10.1177/1090820X10374108

Published

2024-10-13

Issue

Section

Health Sciences

How to Cite

Botulinum toxin and eyelid ptosis: A narrative review. Research, Society and Development, [S. l.], v. 13, n. 10, p. e60131047022, 2024. DOI: 10.33448/rsd-v13i10.47022. Disponível em: https://ojs34.rsdjournal.org/index.php/rsd/article/view/47022. Acesso em: 28 jun. 2025.